Stay updated on Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page.

Latest updates to the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 18, 2025.SummaryDifference1.0%
- Check66 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a future date has been added.SummaryDifference6%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page.